title: Peripheral injections of cholecystokinin, apelin, ghrelin and orexin in cavefish (Astyanax fasciatus mexicanus): effects on feeding and on the brain expression levels of tyrosine hydroxylase, mechanistic target of rapamycin and appetite-related hormones.
abstract: The effects of intraperitoneal injections of cholecystokinin (CCK), apelin, ghrelin, and orexin on food intake were examined in the blind cavefish Astyanax fasciatus mexicanus. CCK (50ng/g) induced a decrease in food intake whereas apelin (100ng/g), orexin (100ng/g), and ghrelin (100ng/g) induced an increase in food intake as compared to saline-injected control fish. In order to better understand the central mechanism by which these hormones act, we examined the effects of injections on the brain mRNA expression of two metabolic enzymes, tyrosine hydroxylase (TH), and mechanistic target of rapamycin (mTOR), and of appetite-regulating peptides, CCK, orexin, apelin and cocaine and amphetamine regulated transcript (CART). CCK injections induced a decrease in brain apelin injections, apelin injections induced an increase in TH, mTOR, and orexin brain expressions, orexin treatment increased brain TH expression and ghrelin injections induced an increase in mTOR and orexin brain expressions. CART expression was not affected by any of the injection treatments. Our results suggest that the enzymes TH and mTOR and the hormones CCK, apelin, orexin, and ghrelin all regulate food intake in cavefish through a complex network of interactions.
authors.affiliation: Departments of Biology and Biochemistry, Memorial University of Newfoundland, St. John's, NL A1B 3X9, Canada.
authors.forename: Carla C
authors.initials: CC
authors.lastname: Penney
authors.affiliation: Departments of Biology and Biochemistry, Memorial University of Newfoundland, St. John's, NL A1B 3X9, Canada. Electronic address: hvolkoff@mun.ca.
authors.forename: Hélène
authors.initials: H
authors.lastname: Volkoff
mesh_terms: D000818:Animals; D001066:Appetite / Q000502:physiology*; D001921:Brain / Q000187:drug effects* / Q000201:enzymology; D060126:Characidae; D018925:Chemokines / Q000008:administration & dosage; D002756:Cholagogues and Choleretics / Q000008:administration & dosage; D002766:Cholecystokinin / Q000008:administration & dosage*; D004435:Eating / Q000187:drug effects*; D054439:Ghrelin / Q000008:administration & dosage*; D006728:Hormones / Q000494:pharmacology*; D007166:Immunosuppressive Agents / Q000494:pharmacology; D047908:Intracellular Signaling Peptides and Proteins / Q000008:administration & dosage*; D009479:Neuropeptides / Q000008:administration & dosage*; D018377:Neurotransmitter Agents / Q000008:administration & dosage; D000068797:Orexins; D012333:RNA, Messenger / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D020123:Sirolimus / Q000494:pharmacology*; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*
chemical_list: D018925:Chemokines; D002756:Cholagogues and Choleretics; D054439:Ghrelin; D006728:Hormones; D007166:Immunosuppressive Agents; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D000068797:Orexins; D012333:RNA, Messenger; D002766:Cholecystokinin; D014446:Tyrosine 3-Monooxygenase; D020123:Sirolimus
keywords: Blind cavefish; Feeding; Hormone; Injection; mRNA expression